The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances
Open accessAbstract
Colorectal cancer (CRC) is the second most commonly diagnosed cancer among females and third among males worldwide. It also contributes significantly to cancer-related deaths, despite the continuous progress in diagnostic and therapeutic methods. Biomarkers currently play an important role in the detection and treatment of patients with colorectal cancer. Risk stratification for screening might be augmented by finding new biomarkers which alone or as a complement of existing tests might recognize either the predisposition or early stage of the disease. Biomarkers have also the potential to change diagnostic and treatment algorithms by selecting the proper chemotherapeutic drugs across a broad spectrum of patients. There are attempts to personalise chemotherapy based on presence or absence of specific biomarkers. In this review, we update review published last year and describe our understanding of tumour markers and biomarkers role in CRC screening, diagnosis, treatment and follow-up. Goal of future research is to identify those biomarkers that could allow a non-invasive and cost-effective diagnosis, as well as to recognise the best prognostic panel and define the predictive biomarkers for available treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Gold, P., & Freedman, S. O. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.121.3.439 · Cited by 2,310
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
De Roock, W., Claes, B., Bernasconi, D., De Schutter, J., Biesmans, B., Fountzilas, G., Kalogeras, K. T., Kotoula, V., Papamichael, D., Laurent-Puig, P., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70130-3 · Cited by 2,144
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Prahallad, A., Sun, C., Huang, S., Di Nicolantonio, F., Salazar, R., Zecchin, D., Beijersbergen, R. L., Bardelli, A., & Bernards, R. (2012) · Nature · doi:10.1038/nature10868 · Cited by 2,051
Van Cutsem, E., Köhne, C.-H., Láng, I., Folprecht, G., Nowacki, M. P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5091 · Cited by 1,882
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Douillard, J.-Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4860 · Cited by 1,809
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2644 · Cited by 1,592
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591
Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds236 · Cited by 1,510
Lièvre, A., Bachet, J.-B., Boige, V., Cayre, A., Le Corre, D., Buc, E., Ychou, M., Bouché, O., Landi, B., Louvet, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5906 · Cited by 1,444
Roth, A. D., Tejpar, S., Delorenzi, M., Yan, P., Fiocca, R., Klingbiel, D., Dietrich, D., Biesmans, B., Bodoky, G., Barone, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3452 · Cited by 1,158
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
Huang, Z., Huang, D., Ni, S., Peng, Z., Sheng, W., & Du, X. (2010) · International Journal of Cancer · doi:10.1002/ijc.25007 · Cited by 964
Maughan, T. S., Adams, R. A., Smith, C. G., Meade, A. M., Seymour, M. T., Wilson, R. H., Idziaszczyk, S., Harris, R., Fisher, D., Kenny, S. L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60613-2 · Cited by 960
Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer
Watanabe, T., Wu, T.-T., Catalano, P. J., Ueki, T., Satriano, R., Haller, D. G., Benson, A. B., & Hamilton, S. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441603 · Cited by 888
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Liao, X., Lochhead, P., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., Imamura, Y., Qian, Z. R., Baba, Y., Shima, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207756 · Cited by 843
Berrino, F., De Angelis, R., Sant, M., Rosso, S., Lasota, M. B., Coebergh, J. W., & Santaquilani, M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70245-0 · Cited by 807
De Roock, W., Jonker, D. J., Di Nicolantonio, F., Sartore-Bianchi, A., Tu, D., Siena, S., Lamba, S., Arena, S., Frattini, M., Piessevaux, H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1535 · Cited by 748
Sartore-Bianchi, A., Martini, M., Molinari, F., Veronese, S., Nichelatti, M., Artale, S., Di Nicolantonio, F., Saletti, P., De Dosso, S., Mazzucchelli, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2466 · Cited by 739
Di Fiore, F., Blanchard, F., Charbonnier, F., Le Pessot, F., Lamy, A., Galais, M. P., Bastit, L., Killian, A., Sesboüé, R., Tuech, J. J., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603685 · Cited by 734
Engstrom, P. F., Arnoletti, J. P., Benson, A. B., Chen, Y.-J., Choti, M. A., Cooper, H. S., Covey, A., Dilawari, R. A., Early, D. S., Enzinger, P. C., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0056 · Cited by 683
Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., Richman, S., Chambers, P., Seymour, M., Kerr, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1366 · Cited by 681
American Joint Committee on Cancer prognostic factors consensus conference: Colorectal working group
Compton, C., Fenoglio-Preiser, C. M., Pettigrew, N., & Fielding, L. P. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7<1739::aid-cncr30>3.0.co;2-t · Cited by 599
Bokemeyer, C., Cutsem, E. V., Rougier, P., Ciardiello, F., Heeger, S., Schlichting, M., Celik, I., & Köhne, C.-H. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.057 · Cited by 585
Elsaleh, H., Joseph, D., Grieu, F., Zeps, N., Spry, N., & Iacopetta, B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02261-3 · Cited by 552
Tveit, K. M., Guren, T., Glimelius, B., Pfeiffer, P., Sorbye, H., Pyrhonen, S., Sigurdsson, F., Kure, E., Ikdahl, T., Skovlund, E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0915 · Cited by 533
Jhawer, M., Goel, S., Wilson, A. J., Montagna, C., Ling, Y.-H., Byun, D.-S., Nasser, S., Arango, D., Shin, J., Klampfer, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5659 · Cited by 460
Siena, S., Sartore-Bianchi, A., Di Nicolantonio, F., Balfour, J., & Bardelli, A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp280 · Cited by 429
Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer
Goldstein, M. J., & Mitchell, E. P. (2005) · Cancer Investigation · doi:10.1081/cnv-58878 · Cited by 419
Russo, A., Bazan, V., Iacopetta, B., Kerr, D., Soussi, T., & Gebbia, N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.471 · Cited by 416
Samowitz, W. S., Curtin, K., Ma, K., Schaffer, D., Coleman, L. W., Leppert, M., & Slattery, M. L. (2001) · PubMed · Cited by 401
Bertagnolli, M. M., Niedzwiecki, D., Compton, C. C., Hahn, H. P., Hall, M., Damas, B., Jewell, S. D., Mayer, R. J., Goldberg, R. M., Saltz, L. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2071 · Cited by 364
Duffy, M. J., Lamerz, R., Haglund, C., Nicolini, A., Kalousová, M., Holubec, L., & Sturgeon, C. (2014) · International Journal of Cancer · doi:10.1002/ijc.28384 · Cited by 360
Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening
Link, A., Balaguer, F., Shen, Y., Nagasaka, T., Lozano, J. J., Boland, C. R., & Goel, A. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0027 · Cited by 354
Tejpar, S., Celik, I., Schlichting, M., Sartorius, U., Bokemeyer, C., & Van Cutsem, E. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.2592 · Cited by 353
Kim, G. P., Colangelo, L. H., Wieand, H. S., Paik, S., Kirsch, I. R., Wolmark, N., & Allegra, C. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8172 · Cited by 342
Labianca, R., Nordlinger, B., Beretta, G. D., Brouquet, A., & Cervantes, A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq168 · Cited by 340
Detection of APC Mutations in Fecal DNA from Patients with Colorectal Tumors
Traverso, G., Shuber, A., Levin, B., Johnson, C., Olsson, L., Schoetz, D. J., Hamilton, S. R., Boynton, K., Kinzler, K. W., & Vogelstein, B. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012294 · Cited by 325
Ogino, S., Nosho, K., Kirkner, G. J., Shima, K., Irahara, N., Kure, S., Chan, A. T., Engelman, J. A., Kraft, P., Cantley, L. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6544 · Cited by 323
Biomarkers to predict the clinical efficacy of bevacizumab in cancer
Jubb, A. M., & Harris, A. L. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70232-1 · Cited by 295
Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia
Ahlquist, D. A., Sargent, D. J., Loprinzi, C. L., Levin, T. R., Rex, D. K., Ahnen, D. J., Knigge, K., Lance, M. P., Burgart, L. J., Hamilton, S. R., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-7-200810070-00004 · Cited by 279
Meyers, M., Wagner, M. W., Hwang, H. S., Kinsella, T. J., & Boothman, D. A. (2001) · PubMed · Cited by 269
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
Liao, X., Morikawa, T., Lochhead, P., Imamura, Y., Kuchiba, A., Yamauchi, M., Nosho, K., Qian, Z. R., Nishihara, R., Meyerhardt, J. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2410 · Cited by 258
Analysis of Mutations in DNA Isolated From Plasma and Stool of Colorectal Cancer Patients
Diehl, F., Schmidt, K., Durkee, K. H., Moore, K. J., Goodman, S. N., Shuber, A. P., Kinzler, K. W., & Vogelstein, B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.039 · Cited by 228
Stool screening for colorectal cancer: Molecular approaches
Osborn, N. K., & Ahlquist, D. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.041 · Cited by 216
Koga, Y., Yasunaga, M., Takahashi, A., Kuroda, J., Moriya, Y., Akasu, T., Fujita, S., Yamamoto, S., Baba, H., & Matsumura, Y. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0036 · Cited by 216
Cecchin, E., Innocenti, F., D'Andrea, M., Corona, G., De Mattia, E., Biason, P., Buonadonna, A., & Toffoli, G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.0314 · Cited by 215
Price, T. J., Hardingham, J. E., Lee, C. K., Weickhardt, A., Townsend, A. R., Wrin, J. W., Chua, A., Shivasami, A., Cummins, M. M., Murone, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.5520 · Cited by 209
NRAS Mutations Are Rare in Colorectal Cancer
Irahara, N., Baba, Y., Nosho, K., Shima, K., Yan, L., Dias-Santagata, D., Iafrate, A. J., Fuchs, C. S., Haigis, K. M., & Ogino, S. (2010) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181c93fd1 · Cited by 194
Popat, S., & Houlston, R. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.039 · Cited by 187
Tejpar, S., Bertagnolli, M., Bosman, F., Lenz, H.-J., Garraway, L., Waldman, F., Warren, R., Bild, A., Collins-Brennan, D., Hahn, H., et al. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0233 · Cited by 185
Thirunavukarasu, P., Sukumar, S., Sathaiah, M., Mahan, M., Pragatheeshwar, K. D., Pingpank, J. F., Zeh, H., Bartels, C. J., Lee, K. K. W., & Bartlett, D. L. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr078 · Cited by 175
Indicators for Treatment Strategies of Colorectal Liver Metastases
Ueno, H., Mochizuki, H., Hatsuse, K., Hase, K., & Yamamoto, T. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00009 · Cited by 161
Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen, C.-C., Yang, S.-H., Lin, J.-K., Lin, T.-C., Chen, W.-S., Jiang, J., Wang, H.-S., & Chang, S. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.08.013 · Cited by 143
Molecular Alterations and Biomarkers in Colorectal Cancer
Grady, W. M., & Pritchard, C. C. (2013) · Toxicologic Pathology · doi:10.1177/0192623313505155 · Cited by 129
Analysis of Fecal DNA Methylation to Detect Gastrointestinal Neoplasia
Nagasaka, T., Tanaka, N., Cullings, H. M., Sun, D.-S., Sasamoto, H., Uchida, T., Koi, M., Nishida, N., Naomoto, Y., Boland, C. R., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp265 · Cited by 128
Watanabe, T., Kobunai, T., Yamamoto, Y., Matsuda, K., Ishihara, S., Nozawa, K., Yamada, H., Hayama, T., Inoue, E., Tamura, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.6490 · Cited by 123
Ogino, S., Nosho, K., Irahara, N., Shima, K., Baba, Y., Kirkner, G. J., Meyerhardt, J. A., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8858 · Cited by 121
Wang, J., Wu, C.-H., Lu, C., Hsieh, J., Wu, D., Huang, S., & Lin, S. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0485-z · Cited by 114
Sood, A., McClain, D., Maitra, R., Basu-Mallick, A., Seetharam, R. N., Kaubisch, A., Rajdev, L. N., Mariadason, J. M., Tanaka, K. E., & Goel, S. (2012) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2011.12.001 · Cited by 111
Aurora-A Expression Is Independently Associated with Chromosomal Instability in Colorectal Cancer
Baba, Y., Nosho, K., Shima, K., Irahara, N., Kure, S., Toyoda, S., Kirkner, G. J., Goel, A., Fuchs, C. S., & Ogino, S. (2009) · Neoplasia · doi:10.1593/neo.09154 · Cited by 109
Leung, W. K., To, K., Man, E. P. S., Chan, M. W. Y., Hui, A. J., Ng, S. S. M., Lau, J., & Sung, J. J. �. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01108.x · Cited by 107
Molecular Tests for Colorectal Cancer Screening
Bosch, L. J. W., Carvalho, B. G., Fijneman, R. J. A., Jiménez, C. R., Pinedo, H. M., van Engeland, M., & Meijer, G. A. (2011) · Clinical Colorectal Cancer · doi:10.3816/ccc.2011.n.002 · Cited by 101
Clinical implications of microsatellite instability in sporadic colon cancers
Sinicrope, F. A., & Sargent, D. J. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32832c94bd · Cited by 91
Colorectal Cancer Biomarkers and the Potential Role of Cancer Stem Cells
Langan, R. C., Mullinax, J. E., Raiji, M. T., Upham, T. C., Summers, T. A., Stojadinovic, A., & Avital, I. (2013) · Journal of Cancer · doi:10.7150/jca.5832 · Cited by 88
Elsaleh, H., & Iacopetta, B. J. (2001) · Clinical Colorectal Cancer · doi:10.3816/ccc.2001.n.010 · Cited by 81
Nielsen, H. J., Brünner, N., Jørgensen, L. N., Olsen, J., Rahr, H. B., Thygesen, K., Høyer, U., Laurberg, S., Stieber, P., Blankenstein, M. A., et al. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.513060 · Cited by 80
Tumor markers in staging and prognosis of colorectal carcinoma.
Levý, M., Visokai, V., Lipská, L., & Topolčan, O. (2008) · PubMed · Cited by 68
Rouits, E., Charasson, V., Pétain, A., Boisdron‐Celle, M., Delord, J., Fonck, M., Laurand, A., Poirier, A.-L., Morel, A., Chatelut, É., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604673 · Cited by 67
CEA, CA 242, CA 19-9, CA 72-4 and hCGβ in the Diagnosis of Recurrent Colorectal Cancer
Carpelan-Holmström, M. A., Louhimo, J. M., Stenman, U.-H., Alfthan, H. V., rvinen, H. J. J., & Haglund, C. H. (2004) · Tumor Biology · doi:10.1159/000081385 · Cited by 67
Jürgensmeier, J. M., Schmoll, H., Robertson, J. D., Brooks, L., Taboada, M., Morgan, S. R., Wilson, D. M., & Hoff, P. M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.79 · Cited by 64
Shen, C., Hu, L., Xia, L., & Li, Y. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn105 · Cited by 58
Nicolini, A., Ferrari, P., Duffy, M. J., Antonelli, A., Rossi, G., Metelli, M. R., Fulceri, F., Anselmi, L., Conte, M., Berti, P., et al. (2010) · Archives of Surgery · doi:10.1001/archsurg.2010.251 · Cited by 57
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
Luo, H., & Xu, R.-H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3858 · Cited by 56
Koss, K., Maxton, D. G., & Jankowski, J. A. (2007) · Colorectal Disease · doi:10.1111/j.1463-1318.2007.01334.x · Cited by 55
Impact of the UGT1A1*28 Allele on Response to Irinotecan: A Systematic Review and Meta-analysis
Dias, M. M., McKinnon, R. A., & Sorich, M. J. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.68 · Cited by 53
Sarli, L., Bottarelli, L., Bader, G., Iusco, D. R., Pizzi, S., Costi, R., D’Adda, T., Bertolani, M., Roncoroni, L., & Bordi, C. (2004) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-0628-6 · Cited by 44
Koga, Y., Yasunaga, M., Moriya, Y., Akasu, T., Fujita, S., Yamamoto, S., Kozu, T., Baba, H., & Matsumura, Y. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00954.x · Cited by 44
Mulder, S. A., van Leerdam, M. E., van Vuuren, A. J., Francke, J., van Toorenenbergen, A. W., Kuipers, E. J., & Ouwendijk, R. J. T. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282cfa49c · Cited by 42
Giessen, C. A., Nagel, D., Glas, M., Spelsberg, F. W., Lau‐Werner, U., Modest, D. P., Michl, M., Heinemann, V., Stieber, P., & Schulz, C. U. (2014) · Tumor Biology · doi:10.1007/s13277-014-2338-6 · Cited by 41
The role of tumor markers and biomarkers in colorectal cancer
Lech, G., Słotwiński, R., & Krasnodebski, I. W. (2013) · Neoplasma · doi:10.4149/neo_2014_003 · Cited by 41
Self-citationEvaluation of predictive markers for patients with advanced colorectal cancer
Byström, P., Berglund, Å., Nygren, P., Wernroth, L., Johansson, B., Larsson, A. O., & Glimelius, B. L. G. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.705020 · Cited by 39
Popat, S., Zhao, D., Chen, Z., Pan, H., Shao, Y., Chandler, I. P., & Houlston, R. S. (2007) · PubMed · Cited by 37
Lumachi, F., Marino, F., Orlando, R., Chiara, G. B., & Basso, S. M. M. (2012) · PubMed · Cited by 37
Ezrin Expression as a Prognostic Marker in Colorectal Adenocarcinoma
Patara, M., Santos, É. M. M., Coudry, R. D. A., Soares, F. A., Ferreira, F. O., & Rossi, B. M. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9389-4 · Cited by 33
Colorectal cancer surveillance: What's new and what's next
Rose, J., Augestad, K. M., & Cooper, G. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i8.1887 · Cited by 32
Adjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: role of CEA and CA 19-9.
Weißenberger, C., Plehn, G. V., Otto, F., Barke, A., Momm, F., & Geißler, M. (2005) · PubMed · Cited by 24
Ezrin expression in rectal cancer predicts time to development of local recurrence
Jörgren, F., Nilbert, M. C., Rambech, E., Bendahl, P., & Lindmark, G. E. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1397-z · Cited by 19
Cited by
Sawicki, T., Ruszkowska, M., Danielewicz, A., Niedźwiedzka, E., Arłukowicz, T., & Przybyłowicz, K. E. (2021) · Cancers · doi:10.3390/cancers13092025 · Cited by 921
A review on ZnO nanostructured materials: energy, environmental and biological applications
Theerthagiri, J., Salla, S., Senthil, R. A., Nithyadharseni, P., Madankumar, A., Arunachalam, P., Maiyalagan, T., & Kim, H.-S. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab268a · Cited by 530
Stefani, C., Miricescu, D., Stanescu-Spinu, I.-I., Nica, R. I., Greabu, M., Totan, A. R., & Jinga, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910260 · Cited by 402
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
Posch, F., Silina, K., Leibl, S., Mündlein, A., Moch, H., Siebenhüner, A., Samaras, P., Riedl, J., Stotz, M., Szkandera, J., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1378844 · Cited by 380
The evolving role of microsatellite instability in colorectal cancer: A review
Gelsomino, F., Barbolini, M., Spallanzani, A., Pugliese, G., & Cascinu, S. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.10.005 · Cited by 313
Metadata
- Authors
- Lech, G.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2016
- Volume
- 22
- Issue
- 5
- Pages
- 1745
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2284098333
- Cited by
- 419
- References
- 90
- FWCI
- 14.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.